Intelligent Investor

Limeade, Inc. (ASX: LME) - Announcements

DELISTED - Current share price for LME : $0.420

ASX company news and announcements for Limeade, Inc. (LME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Limeade, Inc. (LME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Limeade, Inc. (LME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Limeade, Inc. (LME)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Removal from Official List 10 Aug 2023 8:51AM $0.420 $0.420 $0.420 fallen by 0%
- Merger Effective Time 10 Aug 2023 8:42AM $0.420 $0.420 $0.420 fallen by 0%
- Suspension from Quotation 8 Aug 2023 12:06PM $0.420 $0.420 $0.420 fallen by 0%
- Results of Special Meeting 8 Aug 2023 11:50AM $0.420 $0.420 $0.420 fallen by 0%
- Chair's Address to Special Shareholders Meeting 8 Aug 2023 9:46AM $0.420 $0.420 $0.420 fallen by 0%
- Trading Halt 8 Aug 2023 9:04AM $0.420 $0.420 $0.420 fallen by 0%
- Merger Timetable 4 Aug 2023 10:42AM $0.420 $0.420 $0.420 fallen by 0%
- Application for quotation of securities - LME 27 Jul 2023 9:02AM $0.415 $0.420 $0.420 risen by 1.20%
- Notification of cessation of securities - LME 27 Jul 2023 8:55AM $0.415 $0.420 $0.420 risen by 1.20%
- Notice of Special Shareholders Meeting and Proxy Statement 11 Jul 2023 8:49AM $0.395 $0.420 $0.420 risen by 6.33%
- Confirmation of Non-Selection as Future Service Provider 5 Jul 2023 11:05AM $0.395 $0.420 $0.420 risen by 6.33%
- Application for quotation of securities - LME 28 Jun 2023 10:13AM $0.400 $0.420 $0.420 risen by 5%
- Preliminary Proxy Statement relating to WebMD Acquisition 26 Jun 2023 8:31AM $0.400 $0.420 $0.420 risen by 5%
- Notification of cessation of securities - LME 22 Jun 2023 9:43AM $0.400 $0.420 $0.420 risen by 5%
- Ceasing to be a substantial holder 16 Jun 2023 12:23PM $0.408 $0.420 $0.420 risen by 3.07%
- Final Director's Interest Notice (Lisa MacCallum) 15 Jun 2023 4:47PM $0.405 $0.420 $0.420 risen by 3.70%
- Results of 2023 AGM 15 Jun 2023 1:36PM $0.408 $0.420 $0.420 risen by 3.07%
- 2023 AGM - Chair Address and CEO Presentation 15 Jun 2023 9:41AM $0.405 $0.420 $0.420 risen by 3.70%
- Change in substantial holding 14 Jun 2023 2:20PM $0.408 $0.420 $0.420 risen by 3.07%
- Change in substantial holding 13 Jun 2023 4:35PM $0.405 $0.420 $0.420 risen by 3.70%
- Becoming a substantial holder 13 Jun 2023 3:49PM $0.408 $0.420 $0.420 risen by 3.07%
- Notice of WebMD Health Services Transaction Announcement 9 Jun 2023 8:27AM $0.100 $0.420 $0.420 risen by 320%
- WebMD to Acquire Limeade for A$0.425 per Share/CDI in cash 9 Jun 2023 8:26AM $0.100 $0.420 $0.420 risen by 320%
- Notification regarding unquoted securities - LME 24 May 2023 10:05AM $0.150 $0.420 $0.420 risen by 180%
- Application for quotation of securities - LME 24 May 2023 10:03AM $0.150 $0.420 $0.420 risen by 180%

1 - 25 of 366 results

Page 1 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.